细胞外囊泡相关的IGF2BP3调节了Ewing肉瘤细胞迁移,并影响邻近细胞中的PI3K/Akt通路
Caterina Mancarella1, Veronica Giusti1, Giulia Caldoni1
1Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Cancer gene therapy
|June 23, 2023
概括
细胞外囊中的胰岛素样生长因子2mRNA结合蛋白3 (IGF2BP3) 影响了尤文肉瘤细胞的迁移和通信,可能导致瘤异质.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 尤文肉瘤 (EWS) 呈现出显著的瘤内部异质性,使治疗复杂化.
- RNA结合蛋白IGF2BP3的高表达与EWS的不良预后和转移有关.
- 导致EWS异质性的细胞间通信机制尚未完全理解.
研究的目的:
- 调查IGF2BP3作为易溶性介质在尤宁肉瘤内的细胞间通信中的作用.
- 确定IGF2BP3及其相关的细胞外囊泡 (EVs) 对EWS细胞行为和分子通路的影响.
主要方法:
- 来自EWS细胞的细胞超级和细胞外囊泡 (EVs) 中IGF2BP3的量化.
- 从IGF2BP3阳性和阴性EWS细胞中EVs对受体EWS细胞迁移和增殖的影响的评估.
- 在来自IGF2BP3沉默细胞的EV中分析miRNA载荷.
- 研究这些EV对受体细胞PI3K/Akt信号通路的影响.
- 在EWS中差异表达的miRNA与临床EWS组织样本的相关性分析.
主要成果:
- IGF2BP3由EWS细胞分泌,并被包装在EVs中.
- 来自EWS细胞的EVs调节受体细胞迁移,但不增殖,以一种取决于IGF2BP3表达的方式.
- 来自IGF2BP3沉默细胞的EVs表现出改变的miRNA配置文件,并抑制PI3K/Akt通路.
- 在EWS中的特定miRNA签名与IGF2BP3表达水平相关,并且可以区分EWS临床亚型.
结论:
- 通过EVs释放的IGF2BP3在Ewing肉瘤中介细胞间通信起作用.
- 通过EV介导的IGF2BP3及其相关miRNA的转移有助于在EWS中观察到的表型异质性.
- 这些发现突出了IGF2BP3和EVs作为理解和潜在地治疗EWS异质性的潜在目标.
更多相关视频
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


